원래 이름 기록: Gilead Sciences, Inc.

Pharmaceutical formulations, particularly solid oral dosage forms (e.g., tablets) comprising (i) the compound of Formula I in an amount of about 40 wt % to about 70 wt %, (ii) a filler, (iii) a disintegrating agent, (iv) and a lubricant are disclosed, as are uses thereof.

Novel modulators of STAT6 having the general formula (I) or a pharmaceutically acceptable salt or stereoisomer thereof, and their use in therapy, and pharmaceutical compositions comprising said compounds.